EP1027352A4 - Antibakterielle carbapenem-verbindungen, zusammensetzungen und behandlungsmethoden - Google Patents

Antibakterielle carbapenem-verbindungen, zusammensetzungen und behandlungsmethoden

Info

Publication number
EP1027352A4
EP1027352A4 EP98953736A EP98953736A EP1027352A4 EP 1027352 A4 EP1027352 A4 EP 1027352A4 EP 98953736 A EP98953736 A EP 98953736A EP 98953736 A EP98953736 A EP 98953736A EP 1027352 A4 EP1027352 A4 EP 1027352A4
Authority
EP
European Patent Office
Prior art keywords
carbapenemic
compositions
treatment
methods
antibacterial compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP98953736A
Other languages
English (en)
French (fr)
Other versions
EP1027352A1 (de
Inventor
Lovji D Cama
Ronald W Ratcliffe
Robert R Wilkening
Kenneth J Wildonger
Wanying Sun
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9806431.4A external-priority patent/GB9806431D0/en
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of EP1027352A1 publication Critical patent/EP1027352A1/de
Publication of EP1027352A4 publication Critical patent/EP1027352A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/14—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
EP98953736A 1997-10-23 1998-10-19 Antibakterielle carbapenem-verbindungen, zusammensetzungen und behandlungsmethoden Withdrawn EP1027352A4 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US6303197P 1997-10-23 1997-10-23
US63031P 1997-10-23
GB9806431 1998-03-25
GBGB9806431.4A GB9806431D0 (en) 1998-03-25 1998-03-25 Carbapenem antibacterial compounds,compositions containing such compounds and methods of treatment
PCT/US1998/022110 WO1999020627A1 (en) 1997-10-23 1998-10-19 Carbapenem antibacterial compounds, compositions and methods of treatment

Publications (2)

Publication Number Publication Date
EP1027352A1 EP1027352A1 (de) 2000-08-16
EP1027352A4 true EP1027352A4 (de) 2001-09-19

Family

ID=26313358

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98953736A Withdrawn EP1027352A4 (de) 1997-10-23 1998-10-19 Antibakterielle carbapenem-verbindungen, zusammensetzungen und behandlungsmethoden

Country Status (5)

Country Link
EP (1) EP1027352A4 (de)
JP (1) JP2002509856A (de)
AU (1) AU739799B2 (de)
CA (1) CA2306565A1 (de)
WO (1) WO1999020627A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2449060A1 (en) * 2001-06-01 2002-12-12 Nikolai Ignatyev Process for the preparation of compounds containing perfluoroalkanesulfonic acid groups
US9771348B2 (en) 2013-07-25 2017-09-26 Dong-A St Co., Ltd Method for preparing benzamide derivative, novel intermediate used in preparation of benzamide, and method for preparing novel intermediate

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993016080A1 (fr) * 1992-02-06 1993-08-19 Yamanouchi Pharmaceutical Co., Ltd. Nouveau derive de carbapenem
US5451579A (en) * 1994-02-15 1995-09-19 Merck & Co., Inc. 1-β-methyl-carbapenem, compositions containing same and methods of use
WO1997040048A1 (en) * 1996-04-24 1997-10-30 Merck & Co., Inc. Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
WO1998010761A1 (en) * 1996-09-13 1998-03-19 Merck & Co., Inc. Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5756725A (en) * 1996-04-24 1998-05-26 Merck & Co., Inc. Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993016080A1 (fr) * 1992-02-06 1993-08-19 Yamanouchi Pharmaceutical Co., Ltd. Nouveau derive de carbapenem
US5451579A (en) * 1994-02-15 1995-09-19 Merck & Co., Inc. 1-β-methyl-carbapenem, compositions containing same and methods of use
WO1997040048A1 (en) * 1996-04-24 1997-10-30 Merck & Co., Inc. Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
WO1998010761A1 (en) * 1996-09-13 1998-03-19 Merck & Co., Inc. Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9920627A1 *

Also Published As

Publication number Publication date
EP1027352A1 (de) 2000-08-16
AU1103099A (en) 1999-05-10
JP2002509856A (ja) 2002-04-02
CA2306565A1 (en) 1999-04-29
WO1999020627A1 (en) 1999-04-29
AU739799B2 (en) 2001-10-18

Similar Documents

Publication Publication Date Title
CY2018020I2 (el) Θεραπεια της νοσου ρομρε
EP0754042A4 (de) Behandlung von atherosklerose mit imidazolen, die den angiotensin ii-rezeptor blockieren
FI964338A0 (fi) Sellulaasia sisältäviä kankaanhoitoainekoostumuksia
DE69925306D1 (de) Behandlung von kohlenwasserstoffgas
LU90115B1 (fr) Formulation orale de 2-méthyl-thiéno-benzodiazépine
BR9609202A (pt) Composições de limpeza
BR9609132A (pt) Composicão e método de tratamento de semente
BR9608853A (pt) Composições de limpeza
DE69616804D1 (de) Wasserdispergierbare copolyester-ether zusammensetzungen
BR9609857A (pt) Composições de paroxetina de liberação controlada
EP0925046A4 (de) Topische zubereitungen und verfahren zur behandlung von hämorrhoiden
PT1014987E (pt) Composicoes orais de levosimendano
DE69631436D1 (de) Keimtotende geschirspulmittelzusammensetzungen
DE69617652D1 (de) Verminderung des haarwuchses
DE69323303D1 (de) Zusammensetzungen zur Behandlung des trockenen Auges
FR2760189B1 (fr) Composition de traitement capillaire
NO962491D0 (no) Orale formuleringer av S(+)-etodolac
AU6522396A (en) Composition for cleaning or treating human or animal hair
EP1126850A4 (de) Behandlung von retinalerkrankungen
EP0750620A4 (de) Carbapenem-derivate, zusammensetzungen und behandlungsmethoden
DE69913380D1 (de) Zusammensetzung zur behandlung von periodontalen erkrankungen
EP1027007A4 (de) Zahnmedizinische behandlungsmethoden
BR9606974A (pt) Composições orais
NO982562D0 (no) Sammensetning for behandling av smerte
BR9610382A (pt) Composição de tratamento do cableo

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20000523

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU NL PT SE

AX Request for extension of the european patent

Free format text: AL PAYMENT 20000523;LT PAYMENT 20000523;LV PAYMENT 20000523;MK PAYMENT 20000523;RO PAYMENT 20000523;SI PAYMENT 20000523

A4 Supplementary search report drawn up and despatched

Effective date: 20010807

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU NL PT SE

RIC1 Information provided on ipc code assigned before grant

Free format text: 7C 07D 477/14 A, 7A 61K 31/55 B, 7A 61K 31/495 B, 7C 07D 519/00 B

17Q First examination report despatched

Effective date: 20011204

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20040108